Lenox Wealth Advisors’s Acura Pharmaceuticals ACUR Stock Holding History

Lenox Wealth Advisors’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$0	Hold	780	–	–	﹤0.01%	1060
2021 Q4	$0	Hold	780	–	–	﹤0.01%	1028
2021 Q3	$0	Hold	780	–	–	﹤0.01%	814
2021 Q2	$1K	Hold	780	–	–	﹤0.01%	689
2021 Q1	$0	Hold	780	–	–	﹤0.01%	783
2020 Q4	$0	Hold	780	–	–	﹤0.01%	705
2020 Q3	$0	Hold	780	–	–	﹤0.01%	677
2020 Q2	$0	Hold	780	–	–	﹤0.01%	851
2020 Q1	$0	Hold	780	–	–	﹤0.01%	985
2019 Q4	$0	Hold	780	–	–	﹤0.01%	853
2019 Q3	$0	Hold	780	–	–	﹤0.01%	655
2019 Q2	$0	Hold	780	–	–	﹤0.01%	613
2019 Q1	$0	Hold	780	–	–	﹤0.01%	636
2018 Q4	$0	Buy	+780	New	–	﹤0.01%	408

Lenox Wealth Advisors's ACUR Position: Q1 2022 in Review

Lenox Wealth Advisors held its Acura Pharmaceuticals (ACUR) position steady in Q1 2022 at 780 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

Lenox Wealth Advisors first reported a position in ACUR in Q4 2018 and has held it in 14 quarters since. The position peaked at $1K in Q2 2021. 2 funds tracked by Wall St. Rank hold ACUR as of Q1 2022.

Lenox Wealth Advisors held 780 shares of Acura Pharmaceuticals worth $0 as of Q1 2022.
Lenox Wealth Advisors left its Acura Pharmaceuticals share count unchanged in Q1 2022.
Acura Pharmaceuticals made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #1060 holding.
Lenox Wealth Advisors first reported a position in Acura Pharmaceuticals in Q4 2018 and has held it in 14 quarters since.
Lenox Wealth Advisors's Acura Pharmaceuticals position peaked at $1K in Q2 2021.
2 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.